Literature DB >> 10721491

Role of AP-2 in tumor growth and metastasis of human melanoma.

M Bar-Eli1.   

Abstract

We previously demonstrated that expression of the cell surface adhesion molecule MCAM/MUC18 correlates directly with the metastatic potential of human melanoma cells. In addition, the progression of human melanoma towards the metastatic phenotype is associated with loss of expression of the tyrosine-kinase receptor c-KIT. This review summarizes our recent data demonstrating that the expression of both genes is regulated by the AP-2 transcription factor. Moreover, we have observed a loss of AP-2 expression in metastatic melanoma cells. Re-expression of AP-2 in the highly metastatic A375SM cells decreased their tumorigenicity and inhibited their metastatic potential in nude mice. MCAM/MUC18 mRNA and protein expression was significantly downregulated while c-KIT expression was upregulated in the AP-2 transfected cells. Since AP-2 also regulates other genes that are involved in the progression of human melanoma such as E-cadherin, MMP-2, p21WAF-1, HER-2, BCL-2, and insulin like growth factor receptor-1, we propose that loss of AP-2 is a crucial event in the development of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10721491     DOI: 10.1023/a:1006377309524

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  21 in total

1.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Searching for the 'melano-miRs': miR-214 drives melanoma metastasis.

Authors:  Menashe Bar-Eli
Journal:  EMBO J       Date:  2011-05-18       Impact factor: 11.598

3.  Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.

Authors:  Iyoko Katoh; Anna Mírová; Shun-ichi Kurata; Yasushi Murakami; Kenji Horikawa; Natsuko Nakakuki; Takunobu Sakai; Kunihiko Hashimoto; Ayako Maruyama; Takaaki Yonaga; Nahoko Fukunishi; Kohji Moriishi; Hirohisa Hirai
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

Review 4.  Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Authors:  Russell R Braeuer; Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Menashe Bar-Eli
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

5.  AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.

Authors:  Hualei Li; Prabhat C Goswami; Frederick E Domann
Journal:  Neoplasia       Date:  2006-07       Impact factor: 5.715

6.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

7.  Expression and distribution of MUC18 in human uveal melanoma.

Authors:  Kenneth Lai; Vidushi Sharma; Martine J Jager; R Max Conway; Michele C Madigan
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

Review 8.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

9.  Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.

Authors:  Monika H Seltenhammer; Elisabeth Sundström; Claudia Meisslitzer-Ruppitsch; Petra Cejka; Jedrzej Kosiuk; Josef Neumüller; Marlene Almeder; Otto Majdic; Peter Steinberger; Udo M Losert; Johannes Stöckl; Leif Andersson; Johann Sölkner; Monika Vetterlein; Anna Golovko
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-28       Impact factor: 2.416

10.  Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

Authors:  Gabriel J Villares; Maya Zigler; Hua Wang; Vladislava O Melnikova; Hong Wu; Ran Friedman; Michael C Leslie; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Anil K Sood; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.